{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:14:33Z","timestamp":1780586073300,"version":"3.54.1"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dermatol Ther (Heidelb)"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s13555-026-01692-3","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:04:23Z","timestamp":1775063063000},"page":"2829-2835","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dupilumab Improves Prurigo Activity and Severity in Patients with Prurigo Nodularis: A Post Hoc Analysis of Pooled Results from the PRIME and PRIME2 Trials"],"prefix":"10.1007","volume":"16","author":[{"given":"Sonja","family":"Stander","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Zeidler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Msihid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Makhija","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simmi","family":"Wiggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Zahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan B.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-9887-8159","authenticated-orcid":false,"given":"Donia","family":"Bahloul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,1]]},"reference":[{"issue":"2","key":"1692_CR1","doi-asserted-by":"publisher","first-page":"173","DOI":"10.2340\/00015555-2774","volume":"98","author":"C Zeidler","year":"2018","unstructured":"Zeidler C, Tsianakas A, Pereira M, St\u00e4nder H, Yosipovitch G, St\u00e4nder S. Chronic prurigo of nodular type: a review. Acta Derm Venereol. 2018;98(2):173\u20139. https:\/\/doi.org\/10.2340\/00015555-2774.","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"1692_CR2","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1016\/j.jaad.2019.01.052","volume":"80","author":"S St\u00e4nder","year":"2019","unstructured":"St\u00e4nder S, Kwon P, Hirman J, Perlman AJ, Weisshaar E, Metz M, et\u00a0al. Serlopitant reduced pruritus in patients with prurigo nodularis in a phase 2, randomized, placebo-controlled trial. J Am Acad Dermatol. 2019;80(5):1395\u2013402. https:\/\/doi.org\/10.1016\/j.jaad.2019.01.052.","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"1692_CR3","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1038\/s41591-023-02320-9","volume":"29","author":"G Yosipovitch","year":"2023","unstructured":"Yosipovitch G, Mollanazar N, St\u00e4nder S, Kwatra SG, Kim BS, Laws E, et\u00a0al. Dupilumab in patients with prurigo nodularis: two randomized, double-blind, placebo-controlled phase 3 trials. Nat Med. 2023;29(5):1180\u201390. https:\/\/doi.org\/10.1038\/s41591-023-02320-9.","journal-title":"Nat Med"},{"issue":"10","key":"1692_CR4","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1111\/jdv.15040","volume":"32","author":"J P\u00f6lking","year":"2018","unstructured":"P\u00f6lking J, Zeidler C, Schedel F, Osada N, Augustin M, Metze D, et\u00a0al. Prurigo activity score (PAS): validity and reliability of a new instrument to monitor chronic prurigo. J Eur Acad Dermatol Venereol. 2018;32(10):1754\u201360. https:\/\/doi.org\/10.1111\/jdv.15040.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"1692_CR5","doi-asserted-by":"publisher","unstructured":"Zeidler C, Stander S. Standardisierte klinischeErfassung der chronischen Prurigo mittelsPrurigo Activity and Severity Score- von derEntwicklung bis zum Einsatz in klinischenStudien und Praxis. In: JDDG: Journal der Deutschen Dermatologischen Gesellschaft [Internet]. 2023 [zitiert 31. Mai 2023]. S. 9\u201327. Verf\u00fcgbar unter: https:\/\/doi.org\/10.1111\/ddg.15078_g","DOI":"10.1111\/ddg.15078_g"},{"issue":"10","key":"1692_CR6","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1111\/jdv.19961","volume":"38","author":"C Zeidler","year":"2024","unstructured":"Zeidler C, Stander S, Rhoten S, Wratten S, Zhang D, Msihid J, et\u00a0al. Validation of a scoring algorithm for the clinician\u2010reported outcome tool \u201cprurigo activity and severity (PAS)\u201d based on clinical studies of dupilumab in adults with prurigo nodularis. J Eur Acad Dermatol Venereol. 2024;38(10):1954\u201364. https:\/\/doi.org\/10.1111\/jdv.19961.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"10","key":"1692_CR7","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1111\/jdv.20099","volume":"38","author":"SG Kwatra","year":"2024","unstructured":"Kwatra SG, Yosipovitch G, St\u00e4nder S, Guillemin I, Msihid J, Bansal A, et\u00a0al. Responder analysis using clinically meaningful thresholds: post hoc analyses from randomized dupilumab clinical trials in patients with prurigo nodularis. J Eur Acad Dermatol Venereol. 2024;38(10):1965\u201372. https:\/\/doi.org\/10.1111\/jdv.20099.","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Dermatology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13555-026-01692-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13555-026-01692-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T14:54:20Z","timestamp":1780584860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13555-026-01692-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,1]]},"references-count":7,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["1692"],"URL":"https:\/\/doi.org\/10.1007\/s13555-026-01692-3","relation":{},"ISSN":["2193-8210","2190-9172"],"issn-type":[{"value":"2193-8210","type":"print"},{"value":"2190-9172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,1]]},"assertion":[{"value":"29 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Sonja Stander is a speaker and\/or consultant and\/or investigator and\/or has received research funding from Almirall S.A., Amgen Inc., Amgen Europe GmbH, Celldex Therapeutics Inc., Clexio Biosiences Ltd., Focus-Insight Healthtech Group Co. Ltd., Galderma Laboratorium GmbH, Galderma R&D LLC., Galderma S.A., GSK R&D Ltd., Incyte Corporation, Klirna Biotech Inc., Leo Pharma, Lilly Deutschland GmbH, Novartis Pharma GmbH, Sanofi-Aventis Deutschland GmbH, Sanofi Aventis R&D, Sanofi Genzyme Corporation, TouchIME, Vifor Pharma Deutschland GmbH, and P. G. Unna Academy. Sonja Stander is an editorial board member of\n                      Dermatology and Therapy\n                      . Sonja Stander was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Claudia Zeidler is an investigator for Abbvie, Boehringer Ingelheim, Eli Lilly, Galderma, Janssen, Leo Pharma, Novartis, Pfizer, Sanofi, Regeneron, and UCB and has received payment\/honoraria from AbbVie, Beiersdorf, Dermasence, and Leo Pharma. Donia Bahloul, Jerome Msihid, Simmi Wiggins, and Melanie Makhija are employees of Sanofi and may hold stocks and\/or stock options in the company. Joseph Zahn, Ashish Bansal, and Ryan B Thomas are employees of Regeneron Pharmaceuticals Inc. and may hold stocks and\/or stock options in the company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This post hoc analysis used data from the PRIME and PRIME2 trials, which received ethics approval and informed consent from all participants.The study was conducted in accordance with the Declaration of Helsinki, the International Conference on Harmonisation Good Clinical Practice guideline, and applicable regulatory requirements.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}